Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Zymeworks BC Inc. (ZYME) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/24/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
10/21/2022 8-K Quarterly results
10/19/2022 8-K Quarterly results
10/18/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Notice of Alteration",
"Notice of Articles"
10/13/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/13/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/13/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/13/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/13/2022 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
10/13/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/13/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/12/2022 425 Form 425 - Prospectuses and communications, business combinations:
10/12/2022 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Notice of Delisting or Failure to...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
10/04/2022 425 Form 425 - Prospectuses and communications, business combinations:
10/04/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Zymeworks Reminds Shareholders to Vote FOR its Redomicile"
10/03/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Zymeworks Announces Participation in Upcoming Investor Conferences and Early Research & Development Day"
09/26/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/26/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Independent Proxy Advisory Firm ISS Recommends a Vote FOR the Zymeworks Redomicile"
09/22/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/22/2022 8-K Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
09/16/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/16/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Independent Proxy Advisory Firm Glass Lewis Recommends Zymeworks Shareholders Vote FOR Redomicile"
09/12/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "FORM 8-K",
"Zymeworks Reports Preliminary Phase 1 Trial Results for Zanidatamab Zovodotin at European Society for Medical Oncology Annual Congress"
09/08/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/08/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Zymeworks Announces Filing and Mailing of Materials for the Special Meeting to Approve Redomicile to Delaware"
09/06/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Zymeworks Announces Release of ESMO Abstract for Phase 1study of Zanidatamab Zovodotin in Solid Cancers"
09/02/2022 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
09/02/2022 425 Form 425 - Prospectuses and communications, business combinations:
09/02/2022 8-K Other Events  Interactive Data
Docs: "FORM 8-K"
08/26/2022 8-K Unregistered Sales of Equity Securities  Interactive Data
08/19/2022 425 Form 425 - Prospectuses and communications, business combinations:
08/19/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy